Thymosin alpha-1 works at the level of immune cell regulation, promoting the development of regulatory T cells that keep autoimmune responses in check
a lethal dose (LD1) was not achieved in toxicology studies [2,3,4,5,6,7,8]
Li, J., Sun, W., Zhu, X., Mei, Y., Li, W., & Li, J
VISIA imaging analysis showed measurable improvements in skin texture, fine lines, and pigmentation [5]
"FDA Response to three Citizen Petitions against biosimilars" (PDF), FDA , 30 May 2006, archived from the original (PDF) on June 19, 2006, retrieved 23 November 2015 In 2023, the FDA approved a different sustained-release form of growth hormone, Sogroya (somapacitan-beco) (Novo) for both pediatric patients (2.5 years and older) and adult patients, whom have growth failure due to inadequate secretion of endogenous growth hormone (rHGH)
However, wide research in animal models to date suggests that BPC-157 is safe and well-tolerated when properly administered [16]